Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation

被引:205
作者
Shin, HM
Kim, MH
Kim, BH
Jung, SH
Kim, YS
Park, HJ
Hong, JT
Kyung, RM
Kim, Y [1 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
[4] Seoul Natl Univ, Nat Prod Res Inst, Seoul 110460, South Korea
来源
FEBS LETTERS | 2004年 / 571卷 / 1-3期
关键词
aromatic diamine compound; NF-kappa B; I kappa B; pro-inflammatory cytokine; LPS-inducible enzyme;
D O I
10.1016/j.febslet.2004.06.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Methyl-N'-(3-phenyl-propyl)-benzene-1,2-diamine (JSH-23) is a novel chemically synthetic compound. The aromatic diamine JSH-23 compound exhibited inhibitory effect with an IC50 value of 7.1 muM on nuclear factor (NF)-kappaB transcriptional activity in lipopolysaccharide (LPS)-stimulated macrophages; RAW 264.7, and interfered LPS-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. This mechanism of action is very rare for controlling NF-kappaB activation. Furthermore, the compound inhibited not only LPS-induced expressions of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6 and inducible nitric oxide synthase and cyclooxygenase-2 but also LPS-induced apoptosis of the RAW 264.7 cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 21 条
[11]   A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells [J].
Moon, KY ;
Hahn, BS ;
Lee, J ;
Kim, YS .
ANALYTICAL BIOCHEMISTRY, 2001, 292 (01) :17-21
[12]  
Moroianu J, 1998, J CELL BIOCHEM, V70, P231
[13]   The human toll signaling pathway:: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) [J].
Muzio, M ;
Natoli, G ;
Saccani, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2097-2101
[14]   The IL-I receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense [J].
O'Neill, LAJ ;
Dinarello, CA .
IMMUNOLOGY TODAY, 2000, 21 (05) :206-209
[15]   THE UBIQUITIN-PROTEASOME PATHWAY IS REQUIRED FOR PROCESSING THE NF-KAPPA-B1 PRECURSOR PROTEIN AND THE ACTIVATION OF NF-KAPPA-B [J].
PALOMBELLA, VJ ;
RANDO, OJ ;
GOLDBERG, AL ;
MANIATIS, T .
CELL, 1994, 78 (05) :773-785
[16]   CD14 IS A PATTERN-RECOGNITION RECEPTOR [J].
PUGIN, J ;
HEUMANN, D ;
TOMASZ, A ;
KRAVCHENKO, VV ;
AKAMATSU, Y ;
NISHIJIMA, M ;
GLAUSER, MP ;
TOBIAS, PS ;
ULEVITCH, RJ .
IMMUNITY, 1994, 1 (06) :509-516
[17]   NF-KAPPA-B CONTROLS EXPRESSION OF INHIBITOR I-KAPPA-B-ALPHA - EVIDENCE FOR AN INDUCIBLE AUTOREGULATORY PATHWAY [J].
SUN, SC ;
GANCHI, PA ;
BALLARD, DW ;
GREENE, WC .
SCIENCE, 1993, 259 (5103) :1912-1915
[18]   Anti-cytokines and cytokines in the treatment of rheumatoid arthritis [J].
Taylor, PC .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (14) :1095-1106
[19]  
Torgerson TR, 1998, J IMMUNOL, V161, P6084
[20]   A PROTEASOME INHIBITOR PREVENTS ACTIVATION OF NF-KAPPA-B AND STABILIZES A NEWLY PHOSPHORYLATED FORM OF I-KAPPA-B-ALPHA THAT IS STILL BOUND TO NF-KAPPA-B [J].
TRAENCKNER, EBM ;
WILK, S ;
BAEUERLE, PA .
EMBO JOURNAL, 1994, 13 (22) :5433-5441